stockrow
Friday 6 November 2026
Export LIVN’s income statement to Excel — free account
LivaNova PLC
LIVN Healthcare Medical Devices
LivaNova PLC’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 10.7% from fiscal 2024.
- Revenue
- +9.89%
- EPS
- +27.0%
- Free cash flow
- −31.0%
- Total debt
- −31.2%
Quarter to September 2026, against a year earlier
90.21
0.93
−1.02%
Follow LIVN
Alert me
LivaNova PLC (LIVN) Net income
LivaNova PLC's net income for fiscal 2025 was −$242.5M, compared with $63.2M in fiscal 2024. Over the twelve months to 30 September 2026 it was $196.1M. Over the past ten years it has ranged from −$348.8M (fiscal 2020) to $63.2M (fiscal 2024); the current reading is higher than 17% of that period. LivaNova PLC ranks 16th of 149 Medical Devices companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$242.5M | — |
| FY2024 | $63.2M | 260.39% |
| FY2023 | $17.5M | — |
| FY2022 | −$86.2M | — |
| FY2021 | −$135.8M | — |
| FY2020 | −$348.8M | — |
| FY2019 | −$157.6M | — |
| FY2018 | −$189.4M | — |
| FY2017 | −$25.1M | — |
| FY2016 | −$62.8M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $34.3M | (68.41%) |
| Jun 2026 | $108.6M | 386.99% |
| Mar 2026 | $22.3M | (27.87%) |
| Dec 2025 | $30.9M | 15.39% |
| 47 more quarters | Free account |
Against its own ten years
Low −$348.8M
High $63.2M
Ten-year median
−$74.5M
Current reading's percentile
17
Net income against peers
| Company | Net income |
|---|---|
| BIO Bio-Rad Laboratories, Inc. compare | $616.6M |
| LIVN LivaNova PLC | $196.1M |
| HAE Haemonetics Corporation compare | $103.9M |
| ITGR Integer Holdings Corporation compare | $103.7M |
| AXGN AxoGen, Inc. compare | −$31.9M |
| IRTC iRhythm Holdings, Inc. compare | −$38.6M |
| NEOG Neogen Corporation compare | −$56.1M |
| TXG 10x Genomics compare | −$75.1M |
| BRKR Bruker Corporation compare | −$115.7M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on LIVN
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement